Prevalence of epilepsy in Croatia: a population-based survey.

OBJECTIVES: To investigate the prevalence of active epilepsy in Croatia. MATERIAL AND METHODS: Patient data collected by means of questionnaires completed by primary healthcare physicians; epilepsy was previously confirmed in the patients by neurologists or neuropaediatricans. RESULTS: One hundred and twenty-seven of 180 (71%) physicians provided the requested information. The total sample was 212 069 people and of these 1022 had active epilepsy. Prevalence rates (per 1000) for the following age-groups were: age 0-7: 3.5; age 8-18: 6.4; age 19-45: 5.0; age 46-65: 4.7; age >65: 4.4. The age-adjusted prevalence rates for the standard populations were 4.9/1000 (European population) and 5.0/1000 (WHO world population). Fifty-one physicians (29%) stated only the number of patients they considered as having active epilepsy but without the requested details. If their patients were also included, the estimated crude prevalence rate would be 5.5/1000. CONCLUSIONS: It is likely that the prevalence of active epilepsy in Croatia is between 4.8 and 5.5/1000; this is in keeping with findings from other European countries.

Ageing, nutritional status and immune response.

The effects of vitamin supplementation on the age-related decline in immune function was studied in a population of elderly subjects with a high prevalence of low and deficient serum values of vitamin C, vitamin E, riboflavin and pyridoxin, as well as iron and zinc. The immune function was examined by measuring delayed cutaneous hypersensitivity (DCH) after intradermal application of a set of 7 antigens in 72 subjects aged 60-89 years living in two homes for the elderly. The results showed an almost linear statistically significant decline in the DCH test with age (p < 0.01). Vitamin supplementation for a period of 10 weeks significantly improved the biochemical parameters for those vitamins and the age related decline in the DCH test was no longer statistically significant (P > 0.05). No statistically significant changes in DCH were observed in the placebo group. The results of this study suggest that nutrition may be an important determinant of immunocompetence in the elderly.

Serum total, LDL, HDL cholesterol and triglycerides related to age, gender and cigarette smoking in patients with first acute myocardial infarction.

The aim of this study was to examine relationships between total cholesterol, LDL, HDL cholesterol, triglycerides and age, gender, and cigarette smoking in 190 patients (132 men and 58 women) aged 34-87 years with first AMI. The control group included 103 patients (57 men and 46 women) aged 29-90 years without a history of angina pectoris or AMI. High total cholesterol (over 5.2 mmol/L) was observed in 75% of patients with AMI vs. 48% of patients in the control group (p < 0.001). Patients with AMI had significantly higher total cholesterol and LDL cholesterol levels than controls (p < 0.0001). HDL cholesterol levels were significantly lower among patients with AMI than among the control group patients (p < 0.0001). Serum total cholesterol and LDL cholesterol is higher in patients with AMI up to 60 years old, but lower in patients older than 60 years. Women aged less than 50 years had significantly higher HDL cholesterol (p < 0.001), lower LDL cholesterol (p < 0.001), and lower total cholesterol (p < 0.05) than those over 50 years. Smokers with AMI who smoked over 20 cigarettes per day had significantly higher total cholesterol, LDL cholesterol and triglycerides levels than the non-smokers (p < 0.05). These findings suggest important influences of hyperlipoproteinemia and cigarette smoking upon development of myocardial infarction, especially in younger patients.